Flora Growth Corp FLGC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if FLGC is a good fit for your portfolio.
News
-
Aegis Capital Corp. Acted as Sole Bookrunner on a $3.23 Million Underwritten Public Offering for Flora Growth Corp. (NASDAQ:FLGC)
-
Thinking about buying stock in Entera Bio, Ocugen, Mind Medicine, MicroAlgo, or Flora Growth?
-
Germany airs scaled-back plan to legalize cannabis for adult use through buyer clubs
Trading Information
- Previous Close Price
- $1.54
- Day Range
- $1.33–1.61
- 52-Week Range
- $0.63–5.48
- Bid/Ask
- $1.27 / $1.37
- Market Cap
- $14.53 Mil
- Volume/Avg
- 386,382 / 815,627
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.15
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Flora Growth Corp is a multi-national cannabis company that manufactures and distributes consumer packaged goods, cultivates and distributes medicinal cannabis, and distributes pharmaceutical products. Its reportable segments are; the commercial and wholesale segment (FGH and Cosechemos subsidiaries), the house of brands segment (JustCBD, Vessel, and Kasa Wholefoods Company subsidiaries), and the pharmaceuticals segment (Grupo Farmaceutico Cronomed and Breeze Laboratory subsidiaries). Geographically, the company generates revenue from United States, Germany, and the United Kingdom. It derives a majority of its revenue from the United States.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Core
- Total Number of Employees
- 108
- Website
- https://www.floragrowth.com
Valuation
|
Metric
|
FLGC
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 2.15 |
Price/Sales | 0.15 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
FLGC
|
|---|---|
Quick Ratio | 0.70 |
Current Ratio | 1.31 |
Interest Coverage | −523.97 |
Quick Ratio
FLGC
Profitability
|
Metric
|
FLGC
|
|---|---|
Return on Assets (Normalized) | −5.70% |
Return on Equity (Normalized) | −9.75% |
Return on Invested Capital (Normalized) | −8.53% |
Return on Assets
FLGC
Drug Manufacturers - Specialty & Generic Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ZTS
| Zoetis Inc Class A | Zrrsztsrp | Ntjhg | $72.4 Bil | |
MKKGY
| Merck KGaA ADR | Vqjncfkrkp | Mfryysd | $70.8 Bil | |
HLN
| Haleon PLC ADR | Pmlwslrfn | Vgb | $38.2 Bil | |
VTRS
| Viatris Inc | Lmywhrzm | Ndrj | $13.6 Bil | |
RDY
| Dr Reddy's Laboratories Ltd ADR | Cgkfkspf | Hkk | $12.5 Bil | |
CTLT
| Catalent Inc | Vrtvgwcp | Gvpmpyd | $10.1 Bil | |
PRGO
| Perrigo Co PLC | Phnhcpl | Vgtg | $4.3 Bil | |
CURLF
| Curaleaf Holdings Inc | Mychtzt | Gqprc | $3.7 Bil | |
PBH
| Prestige Consumer Healthcare Inc | Mqhxyfxnq | Gbxsqy | $3.5 Bil | |
GTBIF
| Green Thumb Industries Inc | Kjkhxknnxz | Sfpzv | $2.9 Bil |